leucine has been researched along with Polycythemia Vera in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albano, F; Anelli, L; Brunetti, C; Casieri, P; Cellamare, A; Coccaro, N; Impera, L; Minervini, A; Minervini, CF; Ricco, A; Specchia, G; Tota, G; Zagaria, A | 1 |
| Ardanaz, MT; Calasanz, MJ; Cross, NC; Hernández, R; Larráyoz, MJ; Marín, J; Odero, MD; Vidal, MJ; Vizmanos, JL | 1 |
2 other study(ies) available for leucine and Polycythemia Vera
| Article | Year |
|---|---|
IgG-lymphoplasmacytic lymphoma following polycythemia vera: JAK2 V617F and MYD88 L265P mutations separated in the same house.
Topics: Aged; Amino Acid Substitution; Humans; Immunoglobulin G; Janus Kinase 2; Leucine; Male; Mutation, Missense; Myeloid Differentiation Factor 88; Phenylalanine; Polycythemia Vera; Proline; Valine; Waldenstrom Macroglobulinemia | 2014 |
Clinical variability of patients with the t(6;8)(q27;p12) and FGFR1OP-FGFR1 fusion: two further cases.
Topics: Adult; Aged; Analysis of Variance; Burkitt Lymphoma; Chromosomes, Human, Pair 6; Chromosomes, Human, Pair 8; Fatal Outcome; Female; Humans; Leucine; Male; Myeloproliferative Disorders; Oncogene Proteins, Fusion; Polycythemia Vera; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; Receptor, Fibroblast Growth Factor, Type 1; Receptors, Fibroblast Growth Factor; Translocation, Genetic | 2004 |